Clinical Trials on Vaginal Neoplasms

Total 108885 results

Agnese Maria Chiara Rapisarda
ProBioEtna

Recruiting

Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota

Urinary Tract Infections | Bacterial Vaginosis | Candidosis Vaginal

Italy
Sciton

Completed

Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause

Sexual Dysfunction | Vaginal Atrophy | Vaginal Dryness | Dyspareunia | Chronic UTI

United States
The University of Texas Health Science Center at...

Completed

Validity of Patient-Collected Wet Mounts

Candidiasis | Vaginitis | Vaginosis, Bacterial | Vaginal Discharge | Trichomonas

United States
University of Zurich

Unknown

Zurich Fistula Cohort Study

Crohn Disease | Fistula;Rectal | Fistula; Rectouterine | Fistula; Rectovesical | Fistulas Recto Vaginal

Switzerland
PepTonic Medical AB
StatCons; Karolinska Trial Alliance

Recruiting

Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis

Vaginal Candidiasis | Candidal Vulvovaginitis | Vulvovaginal Candidiasis

Sweden
National Institute of Allergy and Infectious Diseases...

Terminated

Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

Vaginal Candidiasis | Microbiome | Antibiotic-Induced VVC

United States
Hutchison Medipharma Limited

Recruiting

Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma

Follicular Lymphoma | Marginal Zone Lymphoma

China
Brown University
Genentech, Inc.

Recruiting

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

Follicular Lymphoma | B-cell Lymphoma | Marginal Zone Lymphoma

United States
Beijing Mabworks Biotech Co., Ltd.

Recruiting

MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)

Follicular Lymphoma and Marginal Zone Lymphoma

China
Seoul National University Hospital
Chonbuk National University Hospital; Seoul National University Bundang Hospital and other collaborators

Completed

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Marginal Zone B-cell Lymphoma

Korea, Republic of
Pharmacyclics LLC.
Janssen Research & Development, LLC

Completed

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma

B-cell Lymphoma | Marginal Zone Lymphoma

United States, Belgium, France, Germany, United Kingdom
Viramal Limited

Completed

Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women

Vaginal Atrophy

United States
Assistance Publique Hopitaux De Marseille

Completed

The Value of Bacterial Loads by Real Time PCR in Predicting Recurrence of Abnormal Vaginal Flora After Oral Metronidazole Therapy

Abnormal Vaginal Flora

France
Medical University of Vienna

Unknown

Small Stitch Study

Anterior Vaginal Wall Prolapse

Austria
Bionovo

Unknown

VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women

Vaginal Atrophy | Vulvar Atrophy

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Extranodal Marginal Zone Lymphoma

United States
Dr. Lila Nachtigall Rapid Medical Research, New...
Se-cure Pharmaceuticals Ltd.

Completed

A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy

Vulvo Vaginal Atrophy

United States
PepTonic Medical AB

Completed

Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women

Vaginal Atrophy | Postmenopause

Sweden, United Kingdom
National Taiwan University Hospital

Not yet recruiting

Lenalidomide and Low-dose Cyclophosphamide for MALT Lymphoma (LCMALT)

Antibiotics-unresponsive MALT Lymphoma | Relapsed MALT Type Extranodal Marginal Zone B-Cell Lymphoma | Refractory Extranodal Marginal Zone B-Cell Lymphoma (MALT)

Taiwan
Hygeia Touch Inc.

Completed

Agreement of hrHPV Type Between Self-collected Sample From Vaginal Fornix and Physician Collected Sample From the Cervical Surface

Human Papillomavirus Infection | Vaginal Discharge | Self Sampling

Taiwan
The Cleveland Clinic

Withdrawn

Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?

Quality of Life | Pelvic Organ Prolapse | Prolapses, Vaginal Vault

United States
University of Colorado, Denver

Completed

Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy

Malignancies | Stenosis of Vagina

United States
Peter Humaidan
Rigshospitalet, Denmark; Statens Serum Institut; Stork Fertility Clinic, VivaNeo... and other collaborators

Active, not recruiting

The Microbiome of Infertile Couples and Its Effect on Their Reproductive Outcomes

Infertility | Abnormal Vaginal Microbiota

Denmark
Agency for Healthcare Research and Quality (AHRQ)

Completed

Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network (VCAT)

Vaginitis

United States
Regeneron Pharmaceuticals

Recruiting

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

Relapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)

Italy, Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Poland, United States, United Kingdom, Turkey, Belgium, Thailand, Czechia
Walden, Jennifer L., M.D.,P.L.L.C.
InMode MD Ltd.; Aviva Preminger, MD., P.L.L.C.

Unknown

Evaluation of Efficacy and Safety of Votiva for Vaginal Rejuvenation

Vaginal Atrophy | Stress Urinary Incontinence | Vaginal Relaxation

United States
Beijing Mabworks Biotech Co., Ltd.

Recruiting

MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma

Follicular Lymphoma and Marginal Zone Lymphoma

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma

Follicular Lymphoma(FL) | Marginal Zone Lymphoma(MZL)

China
Duke University
Celgene

Terminated

Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma

Follicular Lymphoma | Marginal Zone Lymphoma

United States
International Extranodal Lymphoma Study Group (IELSG)

Completed

Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)

Marginal Zone B-cell Lymphoma

Italy, Switzerland, Austria
Far Eastern Memorial Hospital

Completed

Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients

Locally Advanced Cervical Cancer

Taiwan
Marjan Industria e Comercio ltda

Unknown

Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections

Bacterial Vaginosis | Fungal Vaginal Infections

Brazil
Janssen-Cilag, S.A.

Completed

A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis

Vaginitis | Infectious Vaginosis

Mexico
BeiGene

Recruiting

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (MAHOGANY)

Marginal Zone Lymphoma | Relapsed/Refractory Follicular Lymphoma

United States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, Belgium, France, Brazil, Ireland, Czechia, Romania, Portugal, Georgia, Argentina, Poland, Puerto Rico, Austria, Switzerland
Incyte Corporation

Active, not recruiting

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. (InMIND)

Follicular Lymphoma | Marginal Zone Lymphoma

Finland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
University of Miami

Terminated

Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL

Lymphoma | Follicular Lymphoma | Marginal Zone Lymphoma

United States
Mackay Memorial Hospital

Not yet recruiting

Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

Menopause | Vaginal Atrophy | Platelet-rich Plasma | Estrogen Replacement Therapy
Hospices Civils de Lyon

Completed

Ambulatory Prolapse Surgery (PROLAMBU)

Genital Prolapse | Vaginal Floor Prolapse

France
Assistance Publique - Hôpitaux de Paris

Completed

Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection (STREPB17)

Vaginal Colonization With GBS

France
Alma Lasers Inc.
The Cleveland Clinic

Completed

Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects

Atrophy | Vaginal Atrophy | Genital Diseases, Female

United States
First Affiliated Hospital Xi'an Jiaotong University

Unknown

Establishment of a Sensitive System for Analysis of Child-bearing Women Vaginal Microbiota (ESSACWVM)

Vaginitis

China
University of California, San Francisco
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management (COPE)

Fistula | Obstetric Fistula | Fistula, Urinary | Fistula, Vaginal

Ghana
Assiut University

Not yet recruiting

Balloon Vaginoplasty for Treatment of Vaginal-aplasia

Vaginal Abnormality
University Hospitals Cleveland Medical Center

Completed

A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia

Vaginal Dysplasia | Vulvar Dysplasia

United States
Quanta System, S.p.A.

Unknown

Effect of Hybrid Laser 10600+1540 nm on GSM

Vaginal Atrophy | Genitourinary Disease

Spain
Sun Pharmaceutical Industries Limited

Terminated

Efficacy and Safety Of Spil's Estradiol Vaginal Tablet

Vaginal Atrophy | Vulvar Atrophy

India
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

Vulvar and Vaginal Atrophy

United States
Cairo University

Completed

Optimum Misoprostol Dose Prior to Office Hysteroscopy

Infertility | Recurrent Abortion | Abnormal Uterine and Vaginal Bleeding, Unspecified

Egypt
Azienda Sanitaria-Universitaria Integrata di Udine

Completed

Efficacy and Safety of the Application of Local Anaesthetic in Spray to Repair of 1st- 2nd Perineal Lacerations (LISPRAY)

Analgesia | Vaginal Discharge | Perineum; Rupture

Italy
Massachusetts General Hospital
TG Therapeutics

Terminated

Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma

Lymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2

United States

Clinical Trials on Vaginal Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations